Affiliation:
1. All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy
Abstract
The review article analyzes the existing world experience in the use of interferons IFN-α and -γ as well as drugs based on them in clinical veterinary practice in cattle and pigs. The selection of literary sources was carried out on the basis of their relevance and the depth of the research (search retrospectiveness is 30 years). It has been established that IFNs are widely used in the prevention and treatment of both infectious and non-infectious diseases, which can be divided into 3 groups: viral infections, oncological diseases, bacterial and aseptic diseases. The use of IFNs is due to their antiviral activity and immunoregulatory effect. Thus, IFN-α exhibits antiviral activity and is the first line of nonspecific immune defense, an inducer of IFN-γ synthesis and the main coordinator of the body's successful response to a viral infection. At the same time, IFN-γ provides immunoregulatory, anti-inflammatory and mediated antibacterial action by stimulating the production of macrophages and participating in the differentiation of lymphocytes. Clinical efficacy is expressed in a decrease or cessation of the infectious process, a decrease in leukocytosis and neutrophilia, relief of acidotic syndrome, an increase in the body weight of animals and an improvement in the general clinical condition. Currently, IFN therapy is one of the most promising and constantly expanding areas of immunopharmacology and treatment of common respiratory, gastrointestinal, obstetric-gynecological diseases in farm animals.
Publisher
FARC of the North-East named N.V. Rudnitskogo
Reference90 articles.
1. Chevaliez S., Pawlotsky J. M. Interferons and their use in persistent viral infections. Handb Exp Pharmacol. 2009;189:203-241. DOI: https://doi.org/10.1007/978-3-540-79086-0_8
2. George P. M., Badiger R., Alazawi W., Foster G. R., Mitchell J. A. Pharmacology and therapeutic potential of interferons. Pharmacol Ther. 2012;135(1):44-53. DOI: https://doi.org/10.1016/j.pharmthera.2012.03.006
3. Denisov L. A., Sholokhov I. V. Otkrytie interferona i ego klinicheskoe primenenie. [Interferon discovery and its clinical experience]. Infektsionnye bolezni: novosti, mneniya, obuchenie = Infectious diseases. News, Opinions, Training. 2017;(1):23-31. (In Russ.). URL: https://cyberleninka.ru/article/n/otkrytie-interferona-i-ego-klinicheskoe-primenenie
4. Valiev T. T. Klinicheskoe primenenie interferonov: sovremennyy vzglyad na voprosy effektivnosti i bezopasnosti. Obzor literatury. [Interferon clinical use: modern view on efficacy and safety. Literature review]. Pediatriya. Consilium Medicum = Pediatrics. Consilium Medicum. 2020;(3):95-104. (In Russ.). URL: https://www.elibrary.ru/item.asp?id=44155087
5. Vasilevsky I. V., Lavrienko A. V. Kliniko-farmakologicheskoe obosnovanie primeneniya interferonov v klinicheskoy praktike. [Clinico-pharmacological rationale for using interferons in clinical practice]. Zdravookhranenie = Healthcare. 2016;(7):51-63. (In Belarus). URL: https://www.elibrary.ru/item.asp?id=28825240
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献